InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Deborah Waterhouse, Chief Executive Officer. Officer active across 1 companies, notably GSK plc. Cumulatively, 1 disclosures have been published. The latest transaction was disclosed on 12 May 2026 — Purchase. Regulator: RNS (LSE). All data is accessible without signup.
Declarations1 total
£25812 shares@ £21.51210.0000% mcap100.0% of flow
London Stock Exchange (XLON)
RNS:9569357-6·
Ideal exit: 6 Feb 2027 (T+270)
1 of 1 declaration
About Deborah Waterhouse
Deborah Waterhouse is the CEO of ViiV Healthcare and President of Global Health at GSK. In these roles, she oversees the strategy and operations of the company, ensuring its growth and development in the healthcare sector. Her leadership is crucial in achieving the organization's strategic objectives.
